Paraoxonase Activity an Independent Contributor in SARS-CoV-2 Infection-Reference-Cited by-同舟云学术

Paraoxonase Activity an Independent Contributor in SARS-CoV-2 Infection

Published:2022-10-25 Issue: Volume: Page:
ISSN:2687-4245
Container-title:Turkish Journal of Internal Medicine
language:en
Short-container-title:Turk J Int Med

Author:

MOGAREKAR Mukund R¹,RAJAN Pushpa²,DHABE Mahendrakumar G¹,ZINE Rahul M¹

Affiliation:

1. Swami Ramanand Teerth Rural Government Medical College Ambajogai.

2. Swami Ramanand Teerth Rural Government Medical College, Ambajogai

Abstract

Background The aim of the present study was the estimation of serum paraoxonase (PON1) activity in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Material and Methods In this cross-sectional study we estimated serum paraoxonase activity in 73 patients with SARS-CoV-2 infection and 73 healthy controls. Results The results showed that PON1 activity was significantly decreased in patients with SARS-CoV-2 (1.30±0.55 kU/L) than in healthy controls (1.913±0.48 kU/L, p

Publisher

Turkish Journal of Internal Medicine

Subject

General Medicine

Reference29 articles.

1. Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics. 1996 May 1;33(3):498-507. doi: 10.1006/geno.1996.0225.

2. Ng CJ, Wadleigh DJ, Gangopadhyay A, Hama S, Grijalva VR, Navab M, Fogelman AM, Reddy ST. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem. 2001 Nov 30;276(48):44444-9. doi: 10.1074/jbc.M105660200.

3. Mackness MI, Arrol S, Abbott C, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 1993 Dec;104(1-2):129-35. doi: 10.1016/0021-9150(93)90183-u.

4. Proteins and Cell Regulation, vol 6. In: Mackness B, Mackness M, Aviram M, Paragh G, eds. The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism. Netherlands: Springer; 2008:6:103-38.

5. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br J Pharmacol. 1997 Sep;122(2):265-8. doi: 10.1038/sj.bjp.0701390.